Cost-effectiveness of screening for hepatocellular carcinoma: putting the cart before the horse
Alain BraillonGRES, Public Health, Amiens, FranceRuggeri has recently reviewed the cost-effectiveness of screening for hepatocellular carcinoma (HCC).1 However, evidence for effectiveness is still lacking, with only two randomized trials available, both from China, one of which is negative and the o...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-08-01
|
| Series: | Risk Management and Healthcare Policy |
| Online Access: | http://www.dovepress.com/cost-effectiveness-of-screening-for-hepatocellular-carcinoma-putting-t-a10654 |